RIPK1 and RIPK3: critical regulators of inflammation and cell death

Area of Science:

• Molecular Biology
• Immunology
• Cell Biology

Background:

• Receptor-interacting serine/threonine protein kinases 1 and 3 (RIPK1/3) interact via RIP homotypic interaction motifs.
• These kinases mediate necroptosis, a form of programmed cell death involving cell rupture.
• Necroptosis can be triggered by TNF, TLRs, or TCR signaling when caspase-8 is inhibited.

Purpose of the Study:

• To investigate the distinct roles of RIPK1 and RIPK3 in cell death and organismal development.
• To understand the underlying reasons for the differential viability of RIPK1-deficient versus RIPK3-deficient mice.
• To elucidate the complex regulatory mechanisms governing apoptosis and necroptosis.

Main Methods:

• Utilizing mouse models with deficiencies in RIPK1 and RIPK3.
• Performing genetic rescue experiments to analyze kinase function.
• Investigating the signaling pathways involved in necroptosis and apoptosis.

Main Results:

• RIPK1-deficient mice exhibit embryonic lethality, while RIPK3-deficient mice are viable and healthy.
• Genetic rescue experiments provided insights into the differential requirement for RIPK1 and RIPK3.
• Evidence suggests necroptosis contributes to disease pathology, as RIPK3 deficiency ameliorates various disease models.
• Unexpected complexity in the regulation of apoptosis and necroptosis by RIPK1 and RIPK3 was revealed.

Conclusions:

• RIPK1 plays a critical, non-redundant role in organismal viability beyond its function in necroptosis.
• RIPK3 is essential for necroptosis, but its absence does not impair viability, indicating alternative survival pathways.
• The interplay between RIPK1, RIPK3, and caspase-8 is crucial for balancing cell survival and death.
• Further research is needed to fully unravel the intricate regulatory networks of programmed cell death.